(c) 2024 PillSync.com

teriflunomide 7 mg

1 INDICATIONS AND USAGE Teriflunomide tablet is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Teriflunomide is a pyrimidine synthesis inhibitor indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. ( 1 )

MSN LABORATORIES PRIVATE LIMITED


2 years ago HEXAGON BLUE T 7 teriflunomide 7 mg

HEXAGON BLUE T 7

2 years ago HEXAGON BLUE T 7 teriflunomide 7 mg

T 7 HEXAGON BLUE

16 HOW SUPPLIED/STORAGE AND HANDLING

TERIFLUNOMIDE tablets are available as 7 mg and 14 mg tablets. The 14 mg tablet is white to off-white colored, pentagonal shaped, biconvex, film coated tablets, de bossed with "14" on one side and "T" on other side. Each tablet contains 14 mg of

TERIFLUNOMIDE. The 7 mg tablet is white to off-white colored, hexagonal shaped, biconvex, film coated tablets, debossed with "7" on one side and "T" on other side. Each tablet contains 7 mg of

TERIFLUNOMIDE.

TERIFLUNOMIDE 14 mg tablets are supplied as: NDC 69539-033-41 Carton of 28 tablets containing 1 wallet composed of 2 folded blister cards of 14 tablets per blister card NDC 69539-033-30 Bottles of 30

TERIFLUNOMIDE 7 mg tablets are supplied as: NDC 69539-032-41 Carton of 28 tablets containing 1 wallet composed of 2 folded blister cards of 14 tablets per blister card Store at 68°F to 77°F (20°C to 25°C) with excursions permitted between 59°F and 86°F (15°C and 30°C).


More pills like HEXAGON T 7












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site